Stock 600976 JIANMIN PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
56.35 CNY +1.28% Intraday chart for Jianmin Pharmaceutical Group Co.,Ltd. -0.74% -13.64%
Apr. 19 Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Jianmin Pharma Gets Nod to Market Asthma Drug MT

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,895 11,989 7,551 9,916 8,563 - -
Enterprise Value (EV) 1 3,895 11,989 7,551 9,916 8,563 8,563 8,563
P/E ratio 26.4 x 37 x 18.5 x 19.1 x 14 x 11.3 x 9.32 x
Yield - - - 1.84% 2.77% 3.39% -
Capitalization / Revenue - 3.66 x 2.07 x 2.35 x 1.74 x 1.51 x 1.32 x
EV / Revenue - 3.66 x 2.07 x 2.35 x 1.74 x 1.51 x 1.32 x
EV / EBITDA - 29.7 x 15.4 x 15.9 x 11.9 x 10.8 x 8.14 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - 7.75 x 4.09 x 4.45 x 3.09 x 2.55 x 1.99 x
Nbr of stocks (in thousands) 153,399 151,967 151,967 151,967 151,967 - -
Reference price 2 25.39 78.89 49.69 65.25 56.35 56.35 56.35
Announcement Date 3/15/21 3/17/22 3/14/23 3/15/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 3,278 3,641 4,213 4,931 5,680 6,478
EBITDA 1 - 403.2 490.2 625.6 719 790.9 1,052
EBIT 1 - 365.2 442.2 573.9 685.9 844.3 1,025
Operating Margin - 11.14% 12.14% 13.62% 13.91% 14.87% 15.82%
Earnings before Tax (EBT) 1 - 360.9 437.9 571.1 682 840.8 1,021
Net income 1 147.8 324.7 407.6 521.5 619.2 768.2 927.4
Net margin - 9.91% 11.19% 12.38% 12.56% 13.52% 14.32%
EPS 2 0.9600 2.130 2.680 3.410 4.035 5.007 6.045
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - 1.200 1.560 1.910 -
Announcement Date 3/15/21 3/17/22 3/14/23 3/15/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - 22.6% 25.3% 25.5% 22.1% 22.7% 21.4%
ROA (Net income/ Total Assets) - - - 12.5% 12.9% 14.1% 13.9%
Assets 1 - - - 4,168 4,800 5,450 6,672
Book Value Per Share 2 - 10.20 12.10 14.70 18.20 22.10 28.30
Cash Flow per Share 2 - 1.700 1.410 1.750 2.300 2.910 4.510
Capex 1 - - - 61.6 30 42.5 30
Capex / Sales - - - 1.46% 0.61% 0.75% 0.46%
Announcement Date 3/15/21 3/17/22 3/14/23 3/15/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Jianmin Pharmaceutical Group Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.35 CNY
Average target price
87.74 CNY
Spread / Average Target
+55.71%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANMIN PHARMACEUTICAL GROUP CO.,LTD. Stock Jianmin Pharmaceutical Group Co.,Ltd.
-13.64% 1.17B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 332B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.04% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600976 Stock
  4. Financials Jianmin Pharmaceutical Group Co.,Ltd.